X
INSM icon

Xponance’s Insmed INSM Stock Holding History

Xponance’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.15M Buy
48,273
+421
+0.9% +$51K 0.03% 378
2026
Q1 		$7.82M Buy
47,852
+4,810
+11% +$740K 0.06% 264
2025
Q4 		$7.49M Buy
43,042
+16,624
+63% +$3.03M 0.06% 251
2025
Q3 		$3.8M Buy
26,418
+1,577
+6% +$193K 0.03% 390
2025
Q2 		$2.5M Buy
24,841
+11,482
+86% +$878K 0.02% 488
2025
Q1 		$1.02M Buy
13,359
+670
+5% +$51.3K 0.01% 690
2024
Q4 		$876K Buy
12,689
+2,380
+23% +$171K 0.01% 768
2024
Q3 		$753K Buy
10,309
+482
+5% +$35.6K 0.01% 803
2024
Q2 		$658K Buy
9,827
+1,457
+17% +$56.5K 0.01% 820
2024
Q1 		$227K Buy
8,370
+21
+0.3% +$588 ﹤0.01% 1146
2023
Q4 		$259K Buy
+8,349
New +$216K ﹤0.01% 1095

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Xponance's INSM Position: Q2 2026 in Review

Xponance increased its Insmed (INSM) stake by 0.88% in Q2 2026, buying an estimated $51K and bringing the position to 48,273 shares worth $5.15M. The position accounts for 0.03% of the portfolio, ranked #378.

Xponance first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.82M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Xponance held 48,273 shares of Insmed worth $5.15M as of Q2 2026.
  • Xponance bought 421 Insmed shares in Q2 2026, an estimated $51K.
  • Insmed made up 0.03% of Xponance's portfolio in Q2 2026, its #378 holding.
  • Xponance first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
  • Xponance's Insmed position peaked at $7.82M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.